A new study from Sweden suggests that some popular medications used to treat heartburn might increase the risk of kidney ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...

A recent Scientific Reports study investigates whether the association between proton pump inhibitors (PPIs) and the use of histamine-2 receptor antagonists (H2RA) affects the risk of chronic kidney ...

While 50%-80% of PPI prescriptions are unjustified, particularly for unnecessary nonsteroidal anti-inflammatory drug (NSAID)-related ulcer prophylaxis, PPIs remain underprescribed for patients at risk ...